Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial
Use Case
Patient Engagement & Recruitment
As the world watched with anticipation, a biotechnology company’s COVID-19 Phase III clinical trial inched closer to its target enrollment of 30,000 participants but was falling short on inclusion of participants historically underrepresented in clinical trials and disproportionately impacted by COVID-19. The sponsor partnered with Citeline Connect to rapidly fill the enrollment gap.
View related products
Citeline Connect
The end-to-end solution to find, educate, engage, and enroll clinical trial participants worldwide
Trial Portfolio Websites
The comprehensive solution for educating, engaging and enrolling participants across an entire clinical trial portfolio
Citeline Connect Marketplace
A robust recruitment network of 100+ recruitment organizations powering more efficient, effective trial enrollment
